查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1435055

治疗性血浆交换市场：按技术、适应症、产品和最终用户划分 - 全球预测 2023-2030 年

Therapeutic Plasma Exchange Market by Technology (Centrifugation, Membrane Separation), Indication (Hematologic Disorders, Metabolic Disorders, Neurological Disorders), Product, End-user - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

治疗性血浆交换市场规模预计 2022 年为 7,1,047 万美元，2023 年达到 7,9,204 万美元，预计 2030 年将达到 15,2584 万美元，复合年增长率为 10.02%。

治疗性血浆置换的全球市场

主要市场统计
基准年[2022] 71047万美元
预测年份 [2023] 79204万美元
预测年份 [2030] 15.2584亿美元
复合年增长率（%） 10.02%
治疗性血浆置换市场-IMG1

治疗性血浆置换是一种从血液中移除和分离血浆以去除血液中有害物质的医疗程序，通常用于治疗各种自体免疫和神经系统疾病。该市场包括医疗设备等终端用户、替代输液等消耗品、服务供应商、医院、血液中心以及需要这些治疗的患者。治疗性血浆置换主要应用于Guillain-Barré二氏症候群、重症肌无力、血栓性血小板低下紫斑症、多发性硬化症等疾病的治疗。该市场的最终用户可分为医院、专科诊所和门诊病人设施，它们是治疗性血浆置换疗法的主要提供者。市场成长受到自体免疫疾病盛行率增加、医疗基础设施进步、支持性医疗政策以及血浆置换手术有效性和安全性提高等因素的影响。单采技术的创新、疾病需求的增加、医疗投资的快速增加以及良好的报销环境是市场的主要扩张趋势。然而，诸如 TPE 程序成本上升、某些人群缺乏认识、严格的监管障碍以及来自替代疗法的竞争等挑战可能会阻碍市场扩张。然而，增加医疗保健支出、教育和 IT 整合以提高治疗准确性对于市场来说是利润丰厚的机会。为了推动成长，该领域准备在具有成本效益的设备製造、人工智慧在治疗优化中的应用、提高单采材料的品质以及探索新的治疗性血浆交换应用方面取得突破。它预示着技术创新和持续发展的未来。市场活力。

区域洞察

全球治疗性血浆置换 (TPE) 市场在美国和欧洲的成熟度不同，分别受到美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 的严格监管，导致采用率不断提高和创新，我来了。由于自体免疫疾病和严重的盛行率上升，以及受保险覆盖范围和医疗基础设施等因素影响的投资和消费者需求的增加，市场相关性正在增强。已开发国家正注重技术进步来改善TPE，以满足消费者对安全性和效率的高期望。然而，这种成长轨迹与成本控制、监管合规性以及对经过专业培训的人员的需求等挑战相平衡。此外，在欧盟层面，研究是高度协作的，有许多跨境倡议和资助机会，例如支持医疗保健创新的「地平线欧洲」计划提供的资助机会。

由于医疗保健投资的增加和监管障碍的降低，亚洲、非洲和美洲部分地区等新兴市场拥有巨大的潜力，代表着大量开拓的患者群体。

FPNV定位矩阵

FPNV 定位矩阵对于评估治疗性血浆置换市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对治疗性血浆交换市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-治疗性血浆交换市场的市场规模和预测是多少？

2-在治疗性血浆交换市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-治疗性血浆交换市场的技术趋势和法律规范是什么？

4-治疗性血浆交换市场主要供应商的市场占有率是多少？

5-进入治疗性血浆置换市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于自体免疫疾病和心臟病的盛行率不断增加，需要进行治疗性血浆置换
      • 单采技术的进步
    • 抑制因素
      • 与设备和治疗性血浆置换程序相关的成本
    • 机会
      • 神经肌肉疾病治疗性血浆置换技术与免疫调节作用的进展
      • 儿童加护治疗中治疗性血浆置换 (TPE) 的需求迅速增长
    • 任务
      • TPE 中与血浆分离术相关的併发症
  • 市场区隔分析
    • 技术：治疗性血浆置换优先选择膜分离
    • 适应症：广泛使用治疗性血浆置换治疗危及生命的血液疾病
    • 产品：耗材的技术进步需要与血浆置换设备和系统相容
    • 最终用户：采血中心和血液成分提供者拥有更大的用户群和对大规模手术治疗的支持
  • 市场趋势分析
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第六章 治疗性血浆交换市场：依技术分类

  • 离心
  • 膜分离

第七章 治疗性血浆交易市场：依迹象分类

  • 血液疾病
    • 非典型溶血性尿毒症综合症
    • 高黏滞症候群
    • 严重/有症状的冷球蛋白血症
    • 血栓性血小板低下紫斑症
  • 代谢紊乱
  • 神经系统疾病
    • 慢性发炎去髓鞘化神经病变
    • 格林-巴利综合症
    • 多发性硬化症
    • 重症肌无力
    • PANDAS
  • 肾臟疾病
    • 抗体介导的肾臟移植排斥反应
    • 古德帕斯特症候群
    • 韦格纳肉芽肿

第八章 治疗性血浆交换市场：副产品

  • 消耗品
  • 装置

第九章 治疗性血浆交换市场：依最终用户分类

  • 血液采集中心和血液成分供应商
  • 医院及输血中心

第十章 美洲治疗性血浆交易市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区治疗性血浆交易市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的治疗性血浆交易市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强

第14章竞争产品组合

  • 主要公司简介
    • Asahi Kasei Medical Co., Ltd.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Bio Products Laboratory Ltd.
    • Cerus Corporation
    • Charles River Laboratories International, Inc.
    • CSL Behring
    • Elastrin Therapeutics, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Grifols, SA
    • Haemonetics Corporation
    • Infomed SA
    • Kaneka Corporation
    • Kedrion Biopharma Inc.
    • Mallinckrodt PLC
    • Medica SPA
    • Medicap Clinic GmbH
    • MEISE Medizintechnik GmbH
    • Miltenyi Biotec
    • Nikkiso Co., Ltd.
    • Pall Corporation
    • Plasma Technologies, LLC
    • Qingdao Haier Biomedical Co., Ltd
    • Sb-Kawasumi Laboratories, Inc.
    • Terumo BCT, Inc.
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-BC0B37A58A48

[184 Pages Report] The Therapeutic Plasma Exchange Market size was estimated at USD 710.47 million in 2022 and expected to reach USD 792.04 million in 2023, at a CAGR 10.02% to reach USD 1,525.84 million by 2030.

Global Therapeutic Plasma Exchange Market

KEY MARKET STATISTICS
Base Year [2022] USD 710.47 million
Estimated Year [2023] USD 792.04 million
Forecast Year [2030] USD 1,525.84 million
CAGR (%) 10.02%
Therapeutic Plasma Exchange Market - IMG1

Therapeutic plasma exchange is a medical procedure that involves removing and separating plasma from the blood to remove harmful substances from the bloodstream, often used to treat a variety of autoimmune and neurological disorders. The market includes medical devices, consumables such as replacement fluids, service providers, hospitals, blood centers, and end-users such as patients requiring these treatments. Therapeutic plasma exchange is primarily applied in the treatment of conditions such as Guillain-Barre syndrome, myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis, among others. End-users of this market can be segmented into hospitals, specialized clinics, and outpatient facilities, which are the primary providers of therapeutic plasma exchange therapy. Growth in the market is influenced by factors such as the increasing prevalence of autoimmune diseases, advancements in healthcare infrastructure, supportive healthcare policies, and the increased effectiveness and safety of plasma exchange procedures. Innovations in apheresis technology and the climbing cases of diseases required, paired with the surge in healthcare investments and beneficial reimbursement climates are market major market upscaling trends. However, challenges such as the elevated cost of TPE procedures, lack of awareness in certain demographics, strict regulatory barriers, and competition from alternative treatments may hinder market progression. However, increased healthcare expenditure and education, and the integration of IT to refine treatment accuracy are lucrative opportunities in the market. To foster growth, the sector is poised for breakthroughs in cost-effective device manufacturing, the application of artificial intelligence for treatment optimization, enhanced apheresis material quality, and exploration of new therapeutic plasma exchange applications, heralding a future of innovation and sustained market vitality.

Regional Insights

The global therapeutic plasma exchange (TPE) market showcases variable maturity in the United States and Europe leading in adoption and innovation, regulated strictly by the FDA and EMA respectively. Market relevance is bolstered by the escalating incidence of autoimmune diseases and critical ailments, matched with increasing investments and consumer demand influenced by factors such as insurance coverage and healthcare infrastructure. Developed nations focus on technological advancements to ameliorate TPE, striving to meet high consumer expectations for safety and efficiency. This growth trajectory, however, is balanced by the challenges of cost management, regulatory compliance, and the necessity for professionally trained personnel. Additionally, research is highly collaborative at the EU level, with numerous cross-border initiatives and funding opportunities, such as those provided by the Horizon Europe program, which supports innovation in the healthcare sector.

Emerging markets such as those in Asia, Africa, and parts of the Americas present significant potential due to rising healthcare investments and less stringent regulatory hurdles, indicating a vast untapped patient demographic.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Therapeutic Plasma Exchange Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Therapeutic Plasma Exchange Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Plasma Exchange Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Bio Products Laboratory Ltd., Cerus Corporation, Charles River Laboratories International, Inc., CSL Behring, Elastrin Therapeutics, Inc., Fresenius Medical Care AG & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Infomed SA, Kaneka Corporation, Kedrion Biopharma Inc., Mallinckrodt PLC, Medica S.P.A., Medicap Clinic GmbH, MEISE Medizintechnik GmbH, Miltenyi Biotec, Nikkiso Co., Ltd., Pall Corporation, Plasma Technologies, LLC, Qingdao Haier Biomedical Co., Ltd, Sb-Kawasumi Laboratories, Inc., and Terumo BCT, Inc..

Market Segmentation & Coverage

This research report categorizes the Therapeutic Plasma Exchange Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Centrifugation
    • Membrane Separation
  • Indication
    • Hematologic Disorders
      • Atypical Hemolytic Uremic Syndrome
      • Hyperviscosity Syndrome
      • Severe/Symptomatic Cryoglobulinemia
      • Thrombotic Thrombocytopenic Purpura
    • Metabolic Disorders
    • Neurological Disorders
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • Guillain-Barre Syndrome
      • Multiple Sclerosis
      • Myasthenia Gravis
      • PANDAS
    • Renal Disorders
      • Antibody-mediated Renal Transplant Rejection
      • Goodpasture Syndrome
      • Wegener's Granulomatosis
  • Product
    • Consumables
    • Devices
  • End-user
    • Blood Collection Centers & Blood Component Providers
    • Hospitals & Transfusion Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Therapeutic Plasma Exchange Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Therapeutic Plasma Exchange Market?

3. What are the technology trends and regulatory frameworks in the Therapeutic Plasma Exchange Market?

4. What is the market share of the leading vendors in the Therapeutic Plasma Exchange Market?

5. Which modes and strategic moves are suitable for entering the Therapeutic Plasma Exchange Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Therapeutic Plasma Exchange Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need of Therapeutic Plasma Exchange due to Rise in Prevalence of Autoimmune and Cardiac Diseases
      • 5.1.1.2. Technical Advancement in Apheresis Technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Cost Associated with the Devices and Therapeutic Plasma Exchange Procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in Therapeutic Plasma Exchange Technology and its Immunomodulatory Effect in Neuromuscular Diseases
      • 5.1.3.2. Surge in Demand for Therapeutic Plasma Exchange (TPE) in Pediatric Intensive Care
    • 5.1.4. Challenges
      • 5.1.4.1. Complications Associated with the Apheresis Procedure in TPE
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Membrane separation are preferred selection while therapeutic plasma exchange
    • 5.2.2. Indication: Extensive usage of therapeutic plasma exchange for life threatening hematologic disorders
    • 5.2.3. Product: Technological advancement in consumables needs should to be compatible with their plasma exchange devices and systems
    • 5.2.4. End-user: Blood collection centers & blood component providers are commanding larger user base and support for large scale operative treatments
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework
  • 5.10. Client Customization

6. Therapeutic Plasma Exchange Market, by Technology

  • 6.1. Introduction
  • 6.2. Centrifugation
  • 6.3. Membrane Separation

7. Therapeutic Plasma Exchange Market, by Indication

  • 7.1. Introduction
  • 7.2. Hematologic Disorders
    • 7.3.1. Atypical Hemolytic Uremic Syndrome
    • 7.3.2. Hyperviscosity Syndrome
    • 7.3.3. Severe/Symptomatic Cryoglobulinemia
    • 7.3.4. Thrombotic Thrombocytopenic Purpura
  • 7.3. Metabolic Disorders
  • 7.4. Neurological Disorders
    • 7.5.1. Chronic Inflammatory Demyelinating Polyneuropathy
    • 7.5.2. Guillain-Barre Syndrome
    • 7.5.3. Multiple Sclerosis
    • 7.5.4. Myasthenia Gravis
    • 7.5.5. PANDAS
  • 7.5. Renal Disorders
    • 7.6.1. Antibody-mediated Renal Transplant Rejection
    • 7.6.2. Goodpasture Syndrome
    • 7.6.3. Wegener's Granulomatosis

8. Therapeutic Plasma Exchange Market, by Product

  • 8.1. Introduction
  • 8.2. Consumables
  • 8.3. Devices

9. Therapeutic Plasma Exchange Market, by End-user

  • 9.1. Introduction
  • 9.2. Blood Collection Centers & Blood Component Providers
  • 9.3. Hospitals & Transfusion Centers

10. Americas Therapeutic Plasma Exchange Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Therapeutic Plasma Exchange Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Therapeutic Plasma Exchange Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. HealthyLongevity.clinic recently partnered with Dr. Dobri Kiprov
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Dr. Savage Introduces Plasma Exchange for 2024 Weight Loss
      • 13.3.2.2. MaxWell Clinic offers Therapeutic Plasma Exchange (TPE) as a Treatment Option for Dementia, Alzheimer's, Memory Los, and Autoimmune Disease

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Asahi Kasei Medical Co., Ltd.
    • 14.1.2. B. Braun Melsungen AG
    • 14.1.3. Baxter International Inc.
    • 14.1.4. Bio Products Laboratory Ltd.
    • 14.1.5. Cerus Corporation
    • 14.1.6. Charles River Laboratories International, Inc.
    • 14.1.7. CSL Behring
    • 14.1.8. Elastrin Therapeutics, Inc.
    • 14.1.9. Fresenius Medical Care AG & Co. KGaA
    • 14.1.10. Grifols, S.A.
    • 14.1.11. Haemonetics Corporation
    • 14.1.12. Infomed SA
    • 14.1.13. Kaneka Corporation
    • 14.1.14. Kedrion Biopharma Inc.
    • 14.1.15. Mallinckrodt PLC
    • 14.1.16. Medica S.P.A.
    • 14.1.17. Medicap Clinic GmbH
    • 14.1.18. MEISE Medizintechnik GmbH
    • 14.1.19. Miltenyi Biotec
    • 14.1.20. Nikkiso Co., Ltd.
    • 14.1.21. Pall Corporation
    • 14.1.22. Plasma Technologies, LLC
    • 14.1.23. Qingdao Haier Biomedical Co., Ltd
    • 14.1.24. Sb-Kawasumi Laboratories, Inc.
    • 14.1.25. Terumo BCT, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. THERAPEUTIC PLASMA EXCHANGE MARKET RESEARCH PROCESS
  • FIGURE 2. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. THERAPEUTIC PLASMA EXCHANGE MARKET DYNAMICS
  • FIGURE 7. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 8. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 10. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 12. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. THERAPEUTIC PLASMA EXCHANGE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 6. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 9. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 11. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 18. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRE SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 25. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 317